ResearchMoz

Clinical Supply Chain Management - Technologies such as IVRS, CTMS, EDC and RFID Enhance Drug Supply Management

GBI Research
Published Date » 2012-08-22
No. Of Pages » 56
   
 GBI Research, leading business intelligence provider has released its latest research report, entitled Clinical Supply Chain Management Technologies such as IVRS, CTMS, EDC and RFID Enhance Drug Supply Management. The report focuses on the current scenario of clinical supply chain management. Key segments of the clinical supply chain which are covered in the report include labeling, packaging, warehousing, logistics, distribution and destruction of investigational products.  
   
 There has been an increase in the number of developmental drugs, and an expansion in clinical trial sites and the complexity of clinical trials. There has also been an increase in the total number of procedures undertaken per clinical trial.  
   
 Clinical Supply Chain Management (CSCM) is...
Table of Contents

1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 7
1.2 List of Figures 7

2 Clinical Supply Chain Management - Introduction 8

3 Clinical Supply Chain Management - Overview 9

3.1 Overview of Clinical Supply Chains 9
3.1.1 Evolution of Clinical Supply Chains 11

4 Clinical Supply Chain Management - Industry Analysis 12
4.1 Capital Requirement 12
4.2 Skilled Workforce 13
4.3 Competition Among Existing Players 13

5 Clinical Supply Chain Management - Drivers and Restraints 14
5.1 Drivers 14
5.1.1 Increasing Concern for Pharmaceutical Companies to Improve R&D Outcomes 14
5.1.2 Geographic Expansion for Conducting Clinical Trials 14
5.2 Restraints 15
5.2.1 Complex Regulatory System 15
5.2.2 High Cost Involved for Entering the Market and Maintaining Processes 15
5.2.3 Proper Visibility of Products in the Supply Chain (Inventory Visibility and Traceability) 15

6 Clinical Supply Chain Management - Components of the Clinical Supply Chain 16
6.1 Labeling 16
6.2 Packaging 17
6.2.1 Blister Packaging 17
6.2.2 Plastic Bottles 18
6.2.3 Labels and Accessories 18
6.2.4 Pouches and Strip Packs 18
6.2.5 Caps and Closures 18
6.2.6 Secondary Containers 18
6.2.7 Others 18
6.3 Logistics 19
6.3.1 Focus Areas for Logistics 20
6.4 Distribution Models 21
6.4.1 Outsource 22
6.4.2 Build 22
6.4.3 Acquisition 22
6.4.4 Direct Shipping 23
6.4.5 Co-Development 23
6.5 Inventory Management 23
6.6 Destruction and Disposal of Waste 24
6.6.1 Recording of Destruction 24
6.6.2 Methods of Destruction 24

7 Clinical Supply Chain Management - CROs Operate in Clinical Trial Supplies 25
7.1 Key Reasons for Outsourcing of Clinical Trials and Research Processes 25
7.1.1 Different Strategies Adopted by Pharmaceutical Companies to Increase Efficiency 26
7.1.2 Increase in the R&D Costs Against Revenue Growth is a Reason for Outsourcing Clinical Trials to CROs 26
7.1.3 Increasing Drug Failure Rates a Concern for Pharmaceutical Companies 27
7.1.4 Outsourcing Clinical Trials to CROs in Order to Decrease the Time Required for Launching the Product in the Market 27
7.1.5 Outsourcing to Site Management Organizations (SMO) 28
7.1.6 Minimization of Development Risks Through Risk Sharing with CROs is One of the Key Reasons for Outsourcing 29
7.1.7 CROs Can Effectively Manage the Trends in Regulations Governing Clinical Trials 30
7.2 Factors Leading to CSMO Growth 30

8 Clinical Supply Chain Management - Key Challenges for Effective and Efficient Supply Chain Management 31
8.1 Key Factors for Efficient Supply Chain Management in Clinical Trials 31
8.1.1 Planning Issues 31
8.1.2 Manufacturing Issues 31
8.1.3 Distribution Issues 32
8.1.4 Visibility Issues 32
8.1.5 Technical Integration with the Vendors 32

9 Clinical Supply Chain Management - Technological Landscape 33
9.1 Information Technology in R&D 33
9.1.1 Data Management 34
9.1.2 Clinical Data Management System 34
9.1.3 Clinical Data Management Outsourcing 35
9.1.4 Deals in Clinical Trial Data Management Outsourcing 35
9.2 IVRS/IWRS 36
9.2.1 IVRS Provides Real-Time Clinical Trials Data Tracking for the Following 37
9.2.2 Case Study 39
9.3 Clinical Data Management Systems (CDMS)/Clinical Trial Management Systems (CTMS) 40
9.4 Electronic Data Capture (EDC) 41
9.5 Clinical Trial Management System (CTMS) 41
9.6 Radio Frequency Identification (RFID) 42

10 Clinical Supply Chain Management - Regulatory Landscape 43
10.1 The US 43
10.1.1 Important Regulations by the FDA in Proposal 43
10.1.2 FDA Motivating CROs to Use Adaptive Design in Drug Development 43
10.2 Europe 44
10.2.1 The New Pharmacovigilance Legislation 45
10.2.2 Reasons for Passing the New Legislation 45
10.3 Emerging Markets 45
10.4 India 46
10.4.1 Potential Advantages of the Indian CRO Market 46
10.5 China 47
10.5.1 Potential Advantages of the Chinese CRO Market 47

11 Clinical Supply Chain Management - Profiles of Key Players and Key Deals 49
11.1 Profiles of Key Companies in Clinical Supply Chain Management 49
11.1.1 Medidata 49
11.1.2 Catalent 49
11.1.3 Myoderm 49
11.1.4 Cold Chain Technologies 49
11.1.5 Numoda Corporation 49
11.1.6 Fisher Clinical Services 50
11.1.7 Marken 50
11.1.8 Phase Forward 50
11.1.9 Bilcare Global Clinical Supplies 50
11.1.10 Almac Clinical Services 50
11.1.11 BioClinica 51
11.1.12 Aptuit 51
11.1.13 Chiltern 51
11.2 Key Deals among Clinical Supply Management Companies 52
11.2.1 Medidata Solutions Acquired Clinical Force in July 2011 52
11.2.2 Catalent Acquires Clinical Trial Supplies Division of Aptuit LLC in February 2012 52
11.2.3 Ion Beam Applications (IBA) and Bayer Schering Pharma Sign a Deal in 2010 52

12 Clinical Supply Chain Management - Appendix 53
12.1 Market Definitions 53
12.2 Abbreviations 53
12.3 Bibliography 54
12.4 Research Methodology 55
12.4.1 Coverage 55
12.4.2 Secondary Research 55
12.4.3 Primary Research 56
12.4.4 Expert Panel Validation 56
12.5 Contact Us 56
12.6 Disclaimer 56

List of Tables


Table 1: Clinical Supply Chain Management, Clinical Trials in Different Geographies, %, 2012 10
Table 2: Clinical Supply Chain Management, R&D Expenditure Versus Turnover for the Top Ten Pharmaceutical Companies, 2011 27

List of Figures


Figure 1: Clinical Supply Chain Management, Investigational Medicinal Products (IMP) Path, 2012 9
Figure 2: Clinical Supply Chain Management, Clinical Trials in Different Geographies, %, 2012 10
Figure 3: Clinical Supply Chain Management, Illustrative Supply Chain for Clinical Trial Materials, 2012 11
Figure 4: Clinical Supply Chain Management, Capital Requirement, Stages, 2012 12
Figure 5: Clinical Supply Chain Management, Advantages of Geographic Expansion of Clinical Trials, 2012 14
Figure 6: Clinical Supply Chain Management, Types of Clinical Trial Material Packaging, 2012 17
Figure 7: Clinical Supply Chain Management, Key Stages in Distribution of Clinical Trial Material, 2012 19
Figure 8: Clinical Supply Chain Management, Key Focus Areas for Logistics, 2012 20
Figure 9: Clinical Supply Chain Management, Distribution Models, 2012 21
Figure 10: Clinical Supply Chain Management, Segments of Distribution Model, 2012 22
Figure 11: Clinical Supply Chain Management, Inventory Management Stages, 2012 23
Figure 12: Clinical Supply Chain Management, Factors Resulting in Efficient Supply Chain, 2012 25
Figure 13: Clinical Supply Chain Management, R&D Expenditure Versus Turnover for the Top Ten Pharmaceutical Companies, 2011 26
Figure 14: Clinical Supply Chain Management, Key Factors Responsible for Study Timeline Reduction by SMOs, 2011 28
Figure 15: Clinical Supply Chain Management, Site Initiation Process, 2011 29
Figure 16: Clinical Supply Chain Management, Technologies Used for Forecasting, 2012 33
Figure 17: Clinical Supply Chain Management, Clinical Data Management System Flow, Global, 2012 34
Figure 18: Clinical Supply Chain Management, Use of IVRS in the Shipment Request Process for Inventory Management, 2011 37
Figure 19: Clinical Supply Chain Management, Cost Saved by Using IVRS - Reduction in Averages, 2011 39
Figure 20: Clinical Supply Chain Management, Cost of Over-Recruitment by 10% in Different Study Samples, 2011 40
Figure 21: Clinical Supply Chain Management, A Typical Clinical Trial Management System, 2011 42
Figure 22: Clinical Supply Chain Management, EU Legislations, 2011 44

Upcoming Reports:

LED Display Driver And Lighting IC Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
An LED display driver is an IC (integrated circuit) offers the circuitry essential in order to interface common microprocessors or digital systems to LED display. Included on an LED display driver may be a multiplex scan circuitry, static display memory and high current segment and digit drivers for displays. Among these two applications, LED Display Driver and IC Market for the lighting applications are estimated to grow with a high CAGR during forecasted period. Display application holds for the largest share of overall LED driver IC market. This market research report analyses...
Barium Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Barium is an alkali earth metal with high chemical reactivity. Barium has different derivatives which include barium sulfate, barium oxide, barium chloride and barium carbonate, barium nitrate and barium titanate.  Barium and its derivatives has applications which include metal alloys, as a drilling fluid in oil wells, paints and varnishes, inks, plastics, vacuum tubes and rubbers.  Increase in demand of alloys from various applications is anticipated to drive the market. Its alloy is used bearing, creep resistant applications, and additives in steel and high grade steel...
Global Vaccine Market Analysis and Forecast 2011-2016
By - Transparency Market Research
The report contains the global scenario of Vaccine market discussing its details and market figures. The report provides market size and forecast till 2016 for each segment and geography across the globe. It also describes the key influencing factors for the global vaccine market.  The report lists mergers & acquisitions among the major players along with key product developments in the market. The report also provides information about major players in the market as company profiles. Market Overview : The massive growth in the vaccine market globally...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

A Health Tech Incubator Started by GE Healthcare
Oct 30, 2014  
For the very first time, a health tech start up campus has been established by GE Healthcare at its headquarters at Helsinki, Finland. This area already has about twenty such healthcare start ups that are working on cloud services, wireless technologies, apps, and sensors that aim at improving healthcare. The main rationale behind such a step is providing opportunities for further...
Net Earnings of DuPont Increases 52% despite Agricultural Turmoil
Oct 29, 2014  
DuPont - The Wilmington, Del-based leading chemical company faced decline of three percent sales to $7.5 billion in the quarter ending of September 30. The company’s third-quarter earnings were increased by 52 percent to $433 million albeit the slow global growth and agricultural downside.   The company witnessed the biggest drags from chemical sales with eight percent...
Appeal for Sanitization in Construction Industry through Government Regulations: CIOB Ghana
Oct 29, 2014  
Rockson Dogbegah - The Chairman of the Chartered Institute of Building Ghana commented that the construction industry needs a thorough cleaning up and assurance of proper growth. Mr. Dogbegah also said that a few factors are extremely important for a proper development in the construction industry. These include keen adherence to standards, supreme sense of professionalism, and sheer pursuance...
Facebook Hints of Rise in Expenses in 2015, Shares Drop
Oct 29, 2014  
Facebook has announced on Tuesday that it is prepping for a dramatic rise in spending in the year 2015. This warning has come combined with a projected slowdown in the company’s revenues after revenues were analyzed at the end of the third quarter of the year. The plans of such hefty spending in the next financial year by the company are indicative of stress in the investor...
China to Invest in UKs Infrastructure Industry
Oct 28, 2014  
As per industry reports, it is expected that in the year 2015, the UK infrastructure will derive benefits from 105 billion pounds of Chinese money. This will involve a host of Chinese machinery suppliers, contractors, and materials producers. The UK government will be spending about half of 225 billion pounds on its own infrastructure. The investors from China will be investing...